Volume 17, Issue 3, Pages (October 2016)

Slides:



Advertisements
Similar presentations
Volume 11, Issue 6, Pages (May 2015)
Advertisements

Volume 41, Issue 6, Pages (March 2011)
Membrane-Tethered Intracellular Domain of Amphiregulin Promotes Keratinocyte Proliferation  Stefan W. Stoll, Philip E. Stuart, Sylviane Lambert, Alberto.
Volume 81, Issue 1, Pages (January 2012)
Volume 33, Issue 2, Pages (January 2009)
Volume 19, Issue 2, Pages (February 2017)
Shitao Li, Lingyan Wang, Michael A. Berman, Ye Zhang, Martin E. Dorf 
Volume 30, Issue 1, Pages (April 2008)
Volume 6, Issue 1, Pages (January 2014)
Volume 12, Issue 3, Pages (July 2015)
Volume 44, Issue 3, Pages (November 2011)
Rui Pedro Galão, Suzanne Pickering, Rachel Curnock, Stuart J.D. Neil 
Histamine Contributes to Tissue Remodeling via Periostin Expression
Deubiquitination and Activation of AMPK by USP10
Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation  Nan-Lin Wu, Duen-Yi Huang, Li-Fang Wang, Reiji Kannagi,
ASK1 Is Essential for JNK/SAPK Activation by TRAF2
Stefan W. Stoll, Jessica L. Johnson, Yong Li, Laure Rittié, James T
Uc.454 Inhibited Growth by Targeting Heat Shock Protein Family A Member 12B in Non- Small-Cell Lung Cancer  Jun Zhou, Chenghai Wang, Weijuan Gong, Yandan.
Volume 15, Issue 1, Pages (January 2012)
Volume 19, Issue 11, Pages (June 2017)
Volume 18, Issue 13, Pages (March 2017)
Volume 3, Issue 4, Pages (April 2013)
Volume 18, Issue 5, Pages (January 2017)
B Cell Receptor Activation and Chemical Induction Trigger Caspase-Mediated Cleavage of PIAS1 to Facilitate Epstein-Barr Virus Reactivation  Kun Zhang,
Volume 15, Issue 4, Pages (April 2016)
Overexpression of CD109 in the Epidermis Differentially Regulates ALK1 Versus ALK5 Signaling and Modulates Extracellular Matrix Synthesis in the Skin 
Volume 4, Issue 3, Pages (March 2015)
14-3-3σ Regulates Keratinocyte Proliferation and Differentiation by Modulating Yap1 Cellular Localization  Sumitha A.T. Sambandam, Ramesh B. Kasetti,
Yutian Peng, Lois S. Weisman  Developmental Cell 
FOXO3a Is Activated in Response to Hypoxic Stress and Inhibits HIF1-Induced Apoptosis via Regulation of CITED2  Walbert J. Bakker, Isaac S. Harris, Tak.
Volume 6, Issue 1, Pages (January 2014)
Volume 5, Issue 6, Pages (December 2013)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
All-Trans-Retinoic Acid Induces Interleukin-8 via the Nuclear Factor-κB and p38 Mitogen-Activated Protein Kinase Pathways in Normal Human Keratinocytes 
Volume 19, Issue 6, Pages (May 2017)
Shijiao Huang, Danming Tang, Yanzhuang Wang  Developmental Cell 
Volume 3, Issue 6, Pages (December 2014)
A Genetic Screen Identifies TCF3/E2A and TRIAP1 as Pathway-Specific Regulators of the Cellular Response to p53 Activation  Zdenek Andrysik, Jihye Kim,
Volume 17, Issue 8, Pages (November 2016)
Volume 122, Issue 2, Pages (July 2005)
Joseph T. Rodgers, Wilhelm Haas, Steven P. Gygi, Pere Puigserver 
ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression
A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability
Codependent Activators Direct Myoblast-Specific MyoD Transcription
Volume 21, Issue 9, Pages (November 2017)
GRM7 Regulates Embryonic Neurogenesis via CREB and YAP
Paula MacGregor, Nicholas J. Savill, Deborah Hall, Keith R. Matthews 
Volume 115, Issue 2, Pages (October 2003)
Inhibition of PAX3 by TGF-β Modulates Melanocyte Viability
Xuepei Lei, Jianwei Jiao  Stem Cell Reports 
Volume 27, Issue 2, Pages (July 2007)
Activin Signals through SMAD2/3 to Increase Photoreceptor Precursor Yield during Embryonic Stem Cell Differentiation  Amy Q. Lu, Evgenya Y. Popova, Colin.
Stress-Induced Phosphorylation of S
Volume 15, Issue 2, Pages (April 2016)
Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation
Volume 52, Issue 2, Pages (October 2013)
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
Volume 19, Issue 3, Pages (September 2010)
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Volume 24, Issue 6, Pages (December 2016)
Volume 5, Issue 6, Pages (December 2013)
Volume 2, Issue 3, Pages (May 2009)
Vidhya Ramachandran, Khyati H. Shah, Paul K. Herman  Molecular Cell 
Volume 11, Issue 3, Pages (March 2010)
Volume 2, Issue 4, Pages (October 2012)
CDK Phosphorylation of Translation Initiation Factors Couples Protein Translation with Cell-Cycle Transition  Tai An, Yi Liu, Stéphane Gourguechon, Ching.
Volume 19, Issue 6, Pages (May 2017)
Volume 41, Issue 4, Pages (February 2011)
Volume 18, Issue 5, Pages (January 2017)
Nitrogen Regulates AMPK to Control TORC1 Signaling
Presentation transcript:

Volume 17, Issue 3, Pages 660-670 (October 2016) The AMPKα1 Pathway Positively Regulates the Developmental Transition from Proliferation to Quiescence in Trypanosoma brucei  Manuel Saldivia, Gloria Ceballos-Pérez, Jean-Mathieu Bart, Miguel Navarro  Cell Reports  Volume 17, Issue 3, Pages 660-670 (October 2016) DOI: 10.1016/j.celrep.2016.09.041 Copyright © 2016 The Authors Terms and Conditions

Cell Reports 2016 17, 660-670DOI: (10.1016/j.celrep.2016.09.041) Copyright © 2016 The Authors Terms and Conditions

Figure 1 Characterization of AMPK Complexes in Trypanosoma brucei (A) Proteomic analyses identify TbAMPK complexes and associated proteins. Proteins in tables were selected either by a high number of hits (peptides identified by MS/MS) or by a previously described functional or biochemical association with AMPK in other eukaryotes. Two independent affinity purifications using the catalytic subunit TbAMPKα1 or the regulatory subunit TbAMPKβ suggest that AMPKs form two independent and conserved complexes. Proteins present significantly in the negative control sample proteins were subtracted from the lists (see Table S1 for the full list of co-purified proteins and control sample). (B) Co-IP of protein C-TbAMPKβ reveals that two AMPK catalytic α subunits (TbAMPKα1 and TbAMPKα2) bind to AMPKβ. The anti-phospho-Thr172 AMPK antibody recognizes both TbAMPKα subunits. (C) Schematic representation of the conserved regions of the TbAMPK orthologs. The TbAMPKα1 and TbAMPKα2 kinase domains have the conserved activation loop described in other organisms. (D) RNAi targeting TbAMPKα1 and TbAMPKα2 downregulates these proteins, and this downregulation can monitored by western blot analysis using an anti-phospho-AMPKα (Thr172) antibody. To investigate the phosphospecificity of this antibody, protein extracts were incubated with or without a phosphatase inhibitor cocktail (PhosSTOP; Roche) Cell Reports 2016 17, 660-670DOI: (10.1016/j.celrep.2016.09.041) Copyright © 2016 The Authors Terms and Conditions

Figure 2 AMPKα1 Kinase Is Activated in Response to Treatment with Nucleotide Analogs (A) Bloodstream parasites were left untreated or were treated with 1 μM AMP analog (AMP an.) (8-pCPT-2′-O-Me-5′-AMP) for 18 hr. The level of phosphorylated-TbAMPKα1 increased in treated cells compared to non-treated cells. The samples were collected in the early and mid-logarithmic phases of parasite growth to avoid a possible density-response effect due to AMPK activation. (B) As in (A), parasites were treated with 1 μM AMP analog (8-pCPT-2′-O-Me-5′-AMP) for 18 hr and collected for western blot analysis. The level of HA-tagged TbAMPKα1 was not altered after treatment with AMP analog (8-pCPT-2′-O-Me-5′-AMP). (C) TbAMPKα1 activation in AMP analog-treated parasites increases in a time-dependent manner. TbTOR4 expression was reduced in parallel with the increase in TbAMPKα1 phosphorylation. (D) TbAMPKα1 phosphorylation depends on parasite density. Unlike the increase due to allosteric activation, this increase does not affect TbTOR4 expression. One representative western blot is shown; results were repeated two times, and some individual conditions were repeated numerous additional times. Cell Reports 2016 17, 660-670DOI: (10.1016/j.celrep.2016.09.041) Copyright © 2016 The Authors Terms and Conditions

Figure 3 Activation of AMPKα1 Kinase Triggers Remodeling of the Quiescent Stumpy Transcriptome in Bloodstream T. brucei (A) Allosteric activation of TbAMPKα1 by 1 μM AMP analog (8-pCPT-2′-O-Me-5′-AMP) induces similar transcriptome changes that occur during slender to stumpy differentiation. mRNA analyzed by RT-qPCR in cells treated with 1 μM AMP analog for 18 hr and untreated control include genes previously associated with stumpy differentiation; PAD1, PAD2, THT-1, HpHbR, myosin (MYO), VSG221 (MITat 1.2/VSG2), and procyclin. The gene expression levels are represented as the fold changes compared to untreated cells using comparative cycle threshold (Ct) calculations, with two internal standards; the PI3K-related protein (Tb927.2.2260) and the control (C1) protein (Tb10.389.0540). (B) Activation of AMPK using hydrolysable analogs of cyclic-AMP (cAMP) and 8-pCPT-2′-O-Me-5′-AMP (AMP an.) decreased the expression level of the VSG 221 protein as detected by western blot analysis. (C) Constitutively active (CA) HA-TbAMPKα1 lacking a regulatory interaction domain was tagged with the HA epitope and expressed in T. brucei. Two independent clones (A and B) were analyzed by western blot using anti-phospho-AMPKα (Thr172) antibody and anti-HA monoclonal antibody to detect the CA-HA-AMPK. CA-HA-AMPK expression seems to increase the basal phosphorylation level of TbAMPKα1. (D) Expression of CA-HA-AMPK induced gene expression changes characteristic of the stumpy form. Constitutively active AMPK expression results in a transcription remodeling similar to that induced by treatment with an AMP analog (A). All data are reported as the mean ± SEM (n = 3). ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.0001 using the two-tailed t test for paired observations. Cell Reports 2016 17, 660-670DOI: (10.1016/j.celrep.2016.09.041) Copyright © 2016 The Authors Terms and Conditions

Figure 4 Cells Become Resistant to AMP Treatment upon Downregulation of the AMPKα1/2 Kinases (A) Depletion of the AMPKα1/2 subunits using RNAi counteracts the growth defect caused by AMP treatment of bloodstream cells. After 48 hr of AMPKα1/2 depletion using RNAi, T. brucei were treated for 18 hr with an AMP analog. (B) Total RNA was purified from the cells shown in (A), and the expression of the PAD1, PAD2, and VSG 221 mRNA was quantified at the transcriptional level. The regulation of these canonical differentiation genes was compromised by kinase knockdown using RNAi. (C) AMPKα1 can phosphorylate the SAMS peptide in vitro in an AMP-dependent manner. Bloodstream parasites were incubated with or without 10 μM AMP analog (8-pCPT-2′-O-Me-5′-AMP) for 30 min. HA-TbAMPKα1 was immunoprecipitated with an anti-HA agarose matrix. AMPK activity was assayed by [32P]ATP incorporation into the SAMS peptide. The use of compound C (CC) abolished the activation of the kinase. (D) Parasites pretreated with compound C do not show the growth defect phenotype induced by the AMP analog (8-pCPT-2′-O-Me-5′-AMP). The parasites were pretreated with 0.25 μM compound C for 4 hr and then incubated with 1 μM AMP analog for 18 hr. All data are reported as the mean ± SEM (n = 3). ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.0001 using the two-tailed t test for paired observations. Cell Reports 2016 17, 660-670DOI: (10.1016/j.celrep.2016.09.041) Copyright © 2016 The Authors Terms and Conditions

Figure 5 AMPKα1 Inactivation Impairs the Differentiation of T. brucei to the Quiescent Stumpy Form during Infection in Mice (A) Western blot analysis shows AMPKα1 regulation during differentiation from the proliferative slender (SL) form to the quiescent stumpy form in pleomorphic cells grown in vivo. One representative western blot is shown. Experiments were repeated three times. (B) Inhibition of AMPK by compound C increases proliferation in parasites. The mice were treated daily intraperitoneal with 1.5 or 4.5 mg/kg of compound C 72 hr after inoculation with the AnTat 1.1 pleomorphic strain. (C) Analysis of the distribution of the slender versus stumpy form showed that 50% of the compound C-treated parasites remained slender and were less resistant to pH mild-to-low acidic fluctuations. (D) In contrast, the non-treated parasites differentiated to the stumpy form. (E) Stumpy markers such as PAD1 and PAD2 were downregulated after inhibition of TbAMPK with compound C. The gene expression levels are shown as the fold changes compared to untreated cells based on comparative cycle threshold (Ct) calculations using the PI3K-related gene as control. Genes analyzed: PAD1, PAD2, THT-1, HpHbR, and control (C1) protein. The error bars in (B) and (C) were calculated from independent mouse infections (three per mouse per group). All data are reported as the mean ± SEM (n = 3). ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.0001 using the two-tailed t test for paired observations. Cell Reports 2016 17, 660-670DOI: (10.1016/j.celrep.2016.09.041) Copyright © 2016 The Authors Terms and Conditions

Figure 6 AMPKα1 Is Activated in Response to Oxidative Stress (A) AMPKα1 senses oxidative stress induced by exogenous H2O2. Cells were incubated with 25 μM hydrogen peroxide and AMPKα1 phosphorylation analyzed by western blot using phospho-specific antibody at the indicated time points in minutes. The level of phosphorylated AMPKα1 oscillated in AMP analog (AMP an.) (8-pCPT-2′-O-Me-5′-AMP)-treated cells compared to untreated (UT) cells. (B) Depletion of AMPKα1 impairs ROS metabolism. AMPK subunits were depleted by RNAi for 24 hr, and cells were subsequently incubated for 20 min with 50 μM H2O2. Intracellular ROS was assayed by flow cytometry of oxidized CM-H2DCFDA. The effectiveness of AMPK knockdown was examined by western blot analysis. (C) AMPKα1 activation by AMP analog (8-pCPT-2′-O-Me-5′-AMP) improves oxidative metabolism by reducing intracellular ROS levels. The parasites were incubated for 18 hr with 1–10 μM of AMP, washed, and then incubated with 100 μM H2O2 during 30 min. (D) Hydrogen peroxide treatment of cells results in an increase of stumpy-specific gene expression. Histogram showing the relative expression of mRNAs measured by qRT-PCR of U2, HpHbR, PAD1, and PAD2 mRNAs isolated from cells treated with H2O2. The gene expression levels are shown as the fold changes compared to untreated cells (0 min) based on comparative cycle threshold (Ct) calculations using the PI3K-related and control 1 (C1) genes as control. The error bars were calculated from three independent experiments. All data are reported as the mean ± SEM (n = 3). ∗p < 0.05 and ∗∗p < 0.01 using the two-tailed t test for paired observations. (E) ROS fluctuation during in vivo development of parasites to the quiescence stumpy form. AnTat 1.1 pleomorphic strain was infected in mice, and intracellular ROS levels were analyzed at day 3 to 5 post-infection. PAD1 surface expression immunofluorescence analysis of blood-isolated parasites was used to detect stumpy form. Previous to the progression of the quiescence stumpy form, intracellular ROS levels were higher than later when stumpy differentiation is detected. (M) Monomorphic proliferative strain growing in culture is used as control. Statistical differences were found between mice at 4 and 5 days post-infection compared with mice at 3 days. Data represent mean ± SEM (n = 3) calculated from independent mouse infection (three per mouse per group). ∗∗p < 0.01 using the two-tailed t test for paired observations. Cell Reports 2016 17, 660-670DOI: (10.1016/j.celrep.2016.09.041) Copyright © 2016 The Authors Terms and Conditions